This is supported by the finding that TBX2 or TBX3 are overexpressed/amplified in melanoma and various types of cancer and that the degree of overexpression correlates with invasiveness, distant metastasis, and poor prognosis (11, 57–59). The gene discussed is TBX3; the disease is cancer.